We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Surge in Adoption of Next-Gen Non-Invasive DNA Tests for High-Risk Pregnancies to Drive NIPT Market

By LabMedica International staff writers
Posted on 07 Oct 2022
Print article
Image: The global NIPT market is projected to surpass USD 8 billion by the end of 2031 (Photo courtesy of Pexels)
Image: The global NIPT market is projected to surpass USD 8 billion by the end of 2031 (Photo courtesy of Pexels)

The global non-invasive prenatal testing (NIPT) market is projected to register a CAGR of 14.8% between 2022 and 2031 to reach USD 8.4 billion by the end of 2031, driven by an increase in the prevalence of Turners' syndrome and Down's syndrome among newborn babies, as well as a surge in the adoption of next-gen non-invasive DNA tests in high-risk pregnancies.

These are the latest findings of Transparency Market Research (Wilmington, DE, USA), a global market research company.

There has been a rise in cases of Down's syndrome and Turners' syndrome among newborn babies globally which is driving demand in the NIPT market. The popularity of NIPT has been increasing in recent years owing to the ability of this procedure to provide precise test results within a short duration. As a result, the growing adoption of testing is creating lucrative growth prospects for the NIPT market.

Additionally, governments in several countries are implementing favorable policies to provide complete reimbursement of NIPT in the second trimester, resulting in a rise in the adoption of such tests. Moreover, regulatory authorities in several countries are focusing on offering reimbursement for different tests, including non-invasive prenatal tests for chromosomal health issues such as Down's syndrome. These efforts are expected to drive sales of the global NIPT market.

Going forward, growing preference among healthcare professionals for performing next-gen non-invasive DNA tests for high-risk pregnancies is expected to drive sales of the NIPT market. Further, the increasing trend of delaying pregnancy among couples is anticipated to fuel market growth. Also, a surge in the prevalence of pregnancy-related problems in the second or third trimester is likely to contribute to the market growth.

Geographically, the North American NIPT market is anticipated to register the strongest growth during the forecast period owing to an increase in diagnosis and treatment of trisomy health issues, the presence of several key players, and existence of a well-established healthcare infrastructure in the U.S. The Asia Pacific NIPT market is expected to expand at a fast pace due to an increase in maternal age in the region, which can lead to a rise in cases of chromosomal aneuploidies among babies.

Related Links:
Transparency Market Research 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.